The tumor microenvironment modulation market is poised for growth driven by increasing focus on advanced immunotherapies, tumor biology understanding, and combination cancer treatments. Expansion is ...

Researchers discovered that a potential drug developed at Michigan Medicine treats severe fatty liver disease by improving gut health, according to a study published in The Journal of Clinical ...

Researchers at Texas A&M University reported that two intranasal doses of extracellular vesicles derived from human neural ...

Globally recognized leader in early-phase oncology clinical development and experimental therapeuticsStrengthens strategic ...

BCG vaccine altered immune responses and modified amyloid-beta, study shows ...

Wi-Fi standards remain as confusing as ever.

The gut microbiome is no longer viewed as a mere spectator in cancer development – it is increasingly recognized as a key ...

Optical interconnects, leveraging intrinsic advantages such as high bandwidth, low loss, and immunity to electromagnetic interference (EMI), are thus regarded as a promising solution to these barriers ...

Data from ongoing Phase 1 study of AX-0810 in healthy volunteers demonstrated dose-dependent target engagement on all key biomarkers in the ...

Cancer remains notoriously difficult to treat, partly because tumors co‑opt their surrounding environment, including the ...

Sionna Therapeutics targets cystic fibrosis with novel CFTR/NBD1 stabilization; key 2026 readouts and cash runway to 2028.